Modified Crohn's Disease Exclusion Diet and exclusive enteral nutrition (EEN) resolve oral dysbiosis in pediatric Crohn's disease: a prospective cohort study
Inflammatory Bowel Diseases · 01.08.2026 · 32 (8) · 1587-1599
DOI: 10.1093/ibd/izag107 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 20.06.2026. Verfasst von Gary P Moran und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Dental Science, Trinity College Dublin and Dublin Dental University Hospital, Dublin D02 F859, Ireland. Hauptthemen laut MEDLINE: Crohn Disease, Dysbiosis, Enteral Nutrition, Mouth. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Children's Health Foundation, Children's Health Foundation, Dublin, Ireland, Children’s Health Foundation, Dublin, Ireland.
Abstract (Originalsprache)
Background and Aims Changes to the oral microbiome have been reported in patients with Crohn’s disease (CD). The aim of this study was to determine the characteristics and dynamics of the oral microbiome in children randomized to 1 of 2 nutritional treatments for CD.
Methods
Participants (n = 54) in this randomized controlled trial (NCT02843100) received the Crohn’s Disease Exclusion Diet (CDED) with either partial enteral nutrition (PEN; n = 28) or exclusive enteral nutrition (EEN; n = 26). The oral microbiome was assessed via swabs from the dorsum of the tongue and the buccal gingiva by 16S rRNA sequencing at 0, 2, 8, 14, 24, and 52 weeks.
Results
There were no significant differences in primary or clinical outcomes between the 2 groups. Due to the COVID-19 pandemic, sampling by 24 weeks was limited to 34 participants. At week 0, moderate-severe disease activity (Pediatric Crohn’s Disease Activity Index [PCDAI] > 30) was associated with decreased Porphyromonas, Haemophilus, Alloprevotella, Neisseria, and Bergeyella species and increased Actinomyces. As patients entered remission (PCDAI < 10), we observed a restoration in the abundance of these taxa. A modified oral dysbiosis index (MODI) was generated, capable of distinguishing mild from moderate-severe disease activity based on microbiome profiles. Dysbiosis decreased as treatment continued and patients entered remission. Patients on CDED exhibited more significant dysbiosis index changes at weeks 8-24, compared with the EEN group. Application of the index across published oral microbiome data sets validated its ability to discriminate health from CD.
Conclusion
Oral microbiome changes in pediatric CD reflect disease activity and parallel therapeutic response to CDED and EEN over time. Additional validation of the proposed dysbiosis index should be undertaken in adequately powered future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Dental Science, Trinity College Dublin and Dublin Dental University Hospital, Dublin D02 F859, Ireland.
- School of Infection and Immunity, University of Glasgow, Glasgow G12 8TA, United Kingdom.
- Pediatric Gastroenterology and Nutrition Unit, Hospital Regional Universitario de Málaga, Biomedical Research Institute of Malaga (IBIMA), Málaga 29590, Spain.
- Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, British Columbia Children's Hospital, University of British Columbia, Vancouver, BC V6H 3V4, Canada.
- Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, 171 77 Stockholm, Sweden.
- Department of Gastroenterology, Sachs' Children and Youth Hospital, Södersjukhuset, 118 83 Stockholm, Sweden.
ORCID-Profile: Gary P Moran, Gwo-Tzer Ho
Förderung
- Children's Health Foundation
- Children's Health Foundation, Dublin, Ireland
- Children’s Health Foundation, Dublin, Ireland
Zitieren
APA
Moran, G. P., McQuillan, A., Ho, G. T., Whelan, R. J., Navas-López, V. M., Lawrence, S., Rolandsdotter, H., Olen, O., Martín-de-Carpi, J., Sigall Boneh, R., Wine, E., & Hussey, S. (2026). Modified Crohn's Disease Exclusion Diet and exclusive enteral nutrition (EEN) resolve oral dysbiosis in pediatric Crohn's disease: a prospective cohort study. Inflammatory Bowel Diseases, 32(8), 1587-1599. https://doi.org/10.1093/ibd/izag107
Vancouver
Moran GP, McQuillan A, Ho GT, Whelan RJ, Navas-López VM, Lawrence S, et al. Modified Crohn's Disease Exclusion Diet and exclusive enteral nutrition (EEN) resolve oral dysbiosis in pediatric Crohn's disease: a prospective cohort study. Inflammatory Bowel Diseases. 2026;32(8):1587-1599. doi:10.1093/ibd/izag107
BibTeX
@article{Moran2026,
author = {Moran, Gary P and McQuillan, Adam and Ho, Gwo-Tzer and Whelan, Robert J and Navas-López, Víctor Manuel and Lawrence, Sally and Rolandsdotter, Helena and Olen, Ola and Martín-de-Carpi, Javier and Sigall Boneh, Rotem and Wine, Eytan and Hussey, Séamus},
title = {Modified Crohn's Disease Exclusion Diet and exclusive enteral nutrition (EEN) resolve oral dysbiosis in pediatric Crohn's disease: a prospective cohort study},
journal = {Inflammatory Bowel Diseases},
year = {2026},
volume = {32},
number = {8},
pages = {1587--1599},
doi = {10.1093/ibd/izag107}
}
EUVIMED